No Data
No Data
Evercore ISI Raises Price Target on AbbVie to $192 From $180, Keeps Outperform Rating
Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.
Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 78% Return On Equity?
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
AbbVie Analyst Ratings
Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $209
loading...
104656319 : hy
webguybob : so how do we use moo to identify potential high performance stocks in the broader sectors?
73279472 : ok
71768068 webguybob : simply russell2000
webguybob 71768068 : I recently shifted most of my large caps to ishares IWF, so I might be covered?
View more comments...